Barrington Raises Price Target on Cross Country Healthcare to $45 From $41, Affirms Outperform Rating
© MT Newswires 2022
All news about CROSS COUNTRY HEALTHCARE, INC. |
|
|
|
Analyst Recommendations on CROSS COUNTRY HEALTHCARE, INC. |
|
|
| |
|
Sales 2022 |
2 773 M
-
-
|
Net income 2022 |
183 M
-
-
|
Net Debt 2022 |
168 M
-
-
|
P/E ratio 2022 |
5,57x |
Yield 2022 |
- |
|
Capitalization |
1 018 M
1 018 M
-
|
EV / Sales 2022 |
0,43x |
EV / Sales 2023 |
0,36x |
Nbr of Employees |
2 250 |
Free-Float |
94,5% |
|
Chart CROSS COUNTRY HEALTHCARE, INC. |
|
Duration :
Period :
|
 |
|
Technical analysis trends CROSS COUNTRY HEALTHCARE, INC.
| Short Term | Mid-Term | Long Term | Trends | Bearish | Neutral | Bullish |
Income Statement Evolution
|
Mean consensus |
OUTPERFORM |
Number of Analysts |
7 |
Last Close Price |
27,29 $ |
Average target price |
39,33 $ |
Spread / Average Target |
44,1% |
|